Fidelity Select Biotechnology Portfolio (FBIOX) - Health fund with $5.15 Billion in assets. The fund allocates 57.45% of its portfolio to its top 10 holdings. It primarily invests in averagemarketcap cap stocks , with a focus on the cash and equivalents sector.
The largest holding in the fund is ABBVIE INC at 14.26% of total assets. This is followed by AMGEN INC (7.54%) and KRYSTAL BIOTECH INC (7.68%).
| Name | Weight | Owned | Change |
|---|---|---|---|
| ABBVIE INC | 14.26% | - | - |
| AMGEN INC | 7.54% | - | - |
| KRYSTAL BIOTECH INC | 7.68% | - | - |
| Fidelity Securities Lending Cash Central Fund | 3.56% | - | - |
| REGENERON PHARMACEUTICALS INC | 3.02% | - | - |
| VERTEX PHARMACEUTICALS INC | 4.56% | - | - |
| ALNYLAM PHARMACEUTICALS INC | 5.38% | - | - |
| GILEAD SCIENCES INC | 7.26% | - | - |
| UCB SA | 2.22% | - | - |
| ZEALAND PHARMA A/S | 1.97% | - | - |
| ARGENX SE SPONSORED ADR | 2.86% | - | - |
| ASCENDIS PHARMA AS SPON ADR | 2.35% | - | - |
| INSMED INC | 3.51% | - | - |